Clinical Significance of Measuring Prostate-Specific Antigen

被引：10

作者：

Arneth, Borros M. ^{[1
]}

机构：

[1] Johannes Gutenberg Univ Mainz, Inst Clin Chem & Lab Med, Mainz, Germany

来源：

LABMEDICINE | 2009年 / 40卷 / 08期

关键词：

DIGITAL RECTAL EXAMINATION; SERUM; CANCER; MEN; PERCENTAGE; RISK;

D O I：

10.1309/LMEGGGLZ2EDWRXUK

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

The incidence of prostate-specific antigen (PSA) monitoring has increased in recent years. However, interpretation of the results is often ambiguous and leads to uncertainty for both the patient and the treating physician, Advantages and disadvantages of measuring PSA and possibilities for improved interpretation using the variable, PSA quotient are given.

引用

页码：487 / 491

页数：5

共 32 条

[1]

*AM SOC ANDR, 2006, AM SOC ANDR HDB ANDR, pCH8

[2] Biology of prostate-specific antigen [J].

Balk, SP ;

Ko, YJ ;

Bubley, GJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :383-391

[3]

BANEZ L, 2004, JAMA-J AM MED ASSOC, V350, P2275

[4] Prostate-specificy-antigen testing for early diagnosis of prostate cancer. [J].

Barry, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1373-1377

[5] Assessing risk: Does this patient have prostate cancer? [J].

Carter, H. Ballentine .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (08) :506-507

[6] Prostate cancers in men with low PSA levels - Must we find them? [J].

Carter, HB .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2292-2294

[7] LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].

CARTER, HB ;

PEARSON, JD ;

METTER, J ;

BRANT, LJ ;

CHAN, DW ;

ANDRES, R ;

FOZARD, JL ;

WALSH, PC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220

[8] MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].

CATALONA, WJ ;

SMITH, DS ;

RATLIFF, TL ;

DODDS, KM ;

COPLEN, DE ;

YUAN, JJJ ;

PETROS, JA ;

ANDRIOLE, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161

[9] Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial [J].

Catalona, WJ ;

Partin, AW ;

Slawin, KM ;

Brawer, MK ;

Flanigan, RC ;

Patel, A ;

Richie, JP ;

deKernion, JB ;

Walsh, PC ;

Scardino, PT ;

Lange, PH ;

Subong, ENP ;

Parson, RE ;

Gasior, GH ;

Loveland, KG ;

Southwick, PC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1542-1547

[10] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].

Catalona, WJ ;

Smith, DS ;

Ornstein, DK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455

← 1 2 3 4 →